nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A pragmatic tool for drug discovery
|
Bobbitt, David R. |
|
|
25 |
10 |
p. 1773-1774 |
artikel |
2 |
Computational approaches in efflux pump inhibitors: current status and prospects
|
Rathi, Ekta |
|
|
25 |
10 |
p. 1883-1890 |
artikel |
3 |
Contents page 1
|
|
|
|
25 |
10 |
p. i |
artikel |
4 |
Contents page 2
|
|
|
|
25 |
10 |
p. ii |
artikel |
5 |
Derivatization and combination therapy of current COVID-19 therapeutic agents: a review of mechanistic pathways, adverse effects, and binding sites
|
El Kantar, Sally |
|
|
25 |
10 |
p. 1822-1838 |
artikel |
6 |
Exportin 1 inhibition as antiviral therapy
|
Uddin, Md. Hafiz |
|
|
25 |
10 |
p. 1775-1781 |
artikel |
7 |
Fsp3: A new parameter for drug-likeness
|
Wei, Wenxiu |
|
|
25 |
10 |
p. 1839-1845 |
artikel |
8 |
Global clinical trial mobilization for COVID-19: higher, faster, stronger
|
Beall, Reed F. |
|
|
25 |
10 |
p. 1801-1806 |
artikel |
9 |
High-Throughput Screening: today’s biochemical and cell-based approaches
|
Blay, Vincent |
|
|
25 |
10 |
p. 1807-1821 |
artikel |
10 |
Liver says no: the ongoing search for safe catechol O-methyltransferase inhibitors to replace tolcapone
|
Silva, Tiago Barros |
|
|
25 |
10 |
p. 1846-1854 |
artikel |
11 |
Myeloid cell leukemin-1 inhibitors: a growing arsenal for cancer therapy
|
Zhu, Peng-Ju |
|
|
25 |
10 |
p. 1873-1882 |
artikel |
12 |
Optimising proteolysis-targeting chimeras (PROTACs) for oral drug delivery: a drug metabolism and pharmacokinetics perspective
|
Pike, Andy |
|
|
25 |
10 |
p. 1793-1800 |
artikel |
13 |
Patent lifecycle management strategies in open innovation projects
|
Lee, Yeolan |
|
|
25 |
10 |
p. 1782-1785 |
artikel |
14 |
Recent advances in the development of microparticles for pulmonary administration
|
Jain, Harsha |
|
|
25 |
10 |
p. 1865-1872 |
artikel |
15 |
Repositioning chloroquine as antiviral prophylaxis against COVID-19: potential and challenges
|
Chang, Raymond |
|
|
25 |
10 |
p. 1786-1792 |
artikel |
16 |
Scientific diligence for oncology drugs: a pharmacology, translational medicine and clinical perspective
|
Parasrampuria, Dolly A. |
|
|
25 |
10 |
p. 1855-1864 |
artikel |